[Standardized determination of tumor-infiltrating lymphocytes in breast cancer : A prognostic marker for histological diagnosis].
Tumor-infiltrating lymphocytes (TILs) have been identified as prognostic parameter in breast cancer. The aim of this review article is to provide an overview on the clinical and analytical validation of TILs in breast cancer. Summary of international guidelines of the TIL working group as well as clinical and translational studies. Breast carcinomas with a high TIL level have an improved response to neoadjuvant chemotherapy. Triple-negative and HER2-positive carcinomas with increased TIL levels have improved survival. TILs are a new prognostic biomarker for routine histopathological diagnosis.